Skip to main content

Amanda Rodríguez Urrutia

Graduated in Medicine and Surgery at the University of Barcelona (UB) in 2002, obtaining the specialization in psychiatry via MIR. Since 2007 I work as a specialist physician at the Mental Health Service of the hospital. I am currently part of the Resistant Depression Program and I coordinate the Brain-Immune-Gut Unit of the Mental Health Service of the Vall d'Hebron University Hospital.

Institutions of which they are part

Main researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca
Psychiatrics
General Hospital

Amanda Rodríguez Urrutia

Institutions of which they are part

Main researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca
Psychiatrics
General Hospital

Graduated in Medicine and Surgery at the University of Barcelona (UB) in 2002, obtaining the specialization in psychiatry via MIR. Since 2007 I work as a specialist physician at the Mental Health Service of the hospital. I am currently part of the Resistant Depression Program and I coordinate the Brain-Immune-Gut Unit of the Mental Health Service of the Vall d'Hebron University Hospital.

PhD in Psychiatry from the Universitat Autònoma de Barcelona (UAB) in 2017 with the qualification of excellent cum laude and extraordinary award. I am very interested in teaching, I am an associate professor at the Faculty of Medicine, coordinator of tutors of MIR residents and tutor since 2013. Since 2018 I am part of the Hospital Ethics Committee. My main line of research is focused on the dysfunctions of the Brain-Immune-Gut axis and depression. I lead the implementation of the Brain-Immune-Gut line at VHIR together with other groups. I am part of national and international grants (discoverie.eu).

Research lines

Brain-Immune-Gut

IP: Amanda Rodríguez Urrutia

Projects

Active Comparator-controlled, Clinical Trial to Study the Efficacy and Safety of the INtegral Cognitive REMediation program (INCREM) in patients with Depression.

IP: Amanda Rodríguez Urrutia
Collaborators: Natalia Calvo Piñero, Montserrat Corrales De la Cruz, Gemma Nieva Rifa, Marta Gil Gordillo, Active Comparator-controlled, Clinical Trial to Study the Efficacy and Safety of the INtegral Cognitive REMediation program (INC, Silvia Ferrer Moltó, Jordi Morillas Ros, Núria Gallardo Hernández, Julia Vendrell Serres, Active Comparator-controlled, Clinical Trial to Study the Efficacy and Safety of the INtegral Cognitive REMediation program (INC, Gina Aliaga Montané, Thaïs Gabriel Aranega, Laia Anglada Llistosella, Sara García González, Imanol Setien Ramos, Active Comparator-controlled, Clinical Trial to Study the Efficacy and Safety of the INtegral Cognitive REMediation program (INC
Funding agency: Fundació La Marató de TV3
Funding: 60872.31
Reference: 202227-30-31-32-33
Duration: 30/04/2023 - 30/04/2026

Grup consolidat

IP: José Antonio Ramos Quiroga
Collaborators: Pilar Lusilla Palacios, Natalia Calvo Piñero, Amanda Rodríguez Urrutia, Montserrat Corrales De la Cruz, Judit Cabana Dominguez, Marc Ferrer Vinardell, Gemma Nieva Rifa, Mª Dolores Braquehais Conesa, Lara Grau Lopez, Constanza Daigre Blanco, Marta Ribases Haro, Laura Gisbert Gustemps, Vanesa Richarte Fernández, Grup consolidat, Christian Fadeuilhe Grau, Francisco Collazos Sanchez, Silvia Alemany Sierra, Grup consolidat, Gara Arteaga Henriquez, Natalia Llonga Tejedor, Maria Soler Artigas, Jorge Lugo Marin
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00840
Duration: 01/01/2022 - 30/06/2025

Development, dIagnostic and prevention of gender-related Somatic and mental COmorbitiEs in IRritable bowel syndrome In Europe (DISCOvERIE)

IP: Fco Javier Santos Vicente
Collaborators: Beatriz Lobo Alvarez, José Alegre Martin, Amanda Rodríguez Urrutia, Silvia Muñoz Caller, Carmen Alonso Cotoner, Jesus Castro Marrero, Natalia Rodriguez Santas, Ana Maria Gonzalez Castro, Marc Pigrau Pastor, Adoración Nieto Ruiz, Natalia Llonga Tejedor, Alejandro Henao Paez, Consuelo Cammarota
Funding agency: EUROPEAN COMMISSION
Funding: 1148684.84
Reference: DISCOVERIE_H2020-SC1-BHC_2019
Duration: 01/01/2020 - 31/05/2025

NEUROFISIOLOGIA Y NEUROFISIOPATOLOGIA DIGESTIVA

IP: -
Collaborators: Belen Sarto Guerri, Amanda Rodríguez Urrutia, Xavier Merino Casabiel, Joan Dot Bach, Monder Abu-Suboh Abadia, Elizabeth Barba Orozco
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 314600
Reference: SAF2016-76648-R
Duration: 30/12/2016 - 30/06/2021

Related news

Over the course of one week, it will host in-person assessments for 35 families to better understand the progression of the disease and contribute to the development of new therapies.

A project led by the Vall d’Hebron Research Institute (VHIR) in collaboration with FIDMAG Germanes Hospitalàries Research Foundation describes structural and functional brain changes in adolescents with borderline personality disorder (BPD).

A large-scale study involving Vall d’Hebron confirms the genetic relatedness among 14 different psychiatric disorders and groups them into five new families, paving the way for new treatments targeting their shared underlying genetic causes

Related professionals

Fernando Moreno Flores

Fernando Moreno Flores

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Gerard Rubio Basagañas

Gerard Rubio Basagañas

Gestió i Administració
Technological Infrastructure Unit
Digital Transformation Directorate
Read more
Sara Belmonte Calderon

Sara Belmonte Calderon

Research technician
Neurodegenerative Diseases
Read more
Luisa Sofia Silva Alcoser

Luisa Sofia Silva Alcoser

Predoctoral researcher
Translational Molecular Pathology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.